ucart123
cellectis
['myeloid', 'leukemia', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'ameli-01']
today at #ash22: dr. david a. sallman of presents on trial of ucart123v1.2, an anti-cd123 allogeneic car-t cell product at 5:00 p.m. read more 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. News and stories at https://t.co/XaP6iv4q19.